China Diagnostic Reagent Industry Research & Analysis Report 2015

1. Research On China Diagnostic Reagent Industry, 2015 Single User License: US$ 2700 No of Pages: 160 Corporate User License: US$ 3800 www.rnrmarketresearch.com WEBSITE

2. Research on China Diagnostic Reagent Industry, 2015 In-depth analysis of Diagnostic Reagent Industry in China, 2015 Report. After 30 years of development, the China's diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals.  There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.  ViewComplete Report @ http://www.rnrmarketresearch.com/research-on-china-diagnostic-reagent-industry- 2015-market-report.html

3. Research on China Diagnostic Reagent Industry, 2015 Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China's diagnostic reagent market in 2014, especially in high-end fields. The market share of domestic enterprises mainly comes from biochemical reagents.  China has fulfilled the import substitution of biochemical reagents, intensified competition has largely squeezed the profits in this subfield. Chemiluminescence Immunoassay (CLIA) and molecular diagnosis will be the most promising subfields in China's diagnostic reagent industry.  Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392985

4. Research on China Diagnostic Reagent Industry, 2015 New Industries Biomedical Engineering Co., Ltd is the leading CLIA enterprise in China. Currently the company owns 102 chemiluminescent reagents and 8 models of CLIA analyzer. The company achieved reagents sales of RMB 331 million and reagents products has exported to Swiss, France, and Italy etc.  Zeesan Biotech is the leading molecular diagnosis enterprise in China. The company achieved molecular diagnosis reagents sales of RMB 11.85 million in 2014. Zeesan's products covers infectious disease (mainly phthisis), tumor (mainly leukemia) and genetic disease.  Access Report by Chisult Insight at http://www.rnrmarketresearch.com/publisher/Chisult-Insight.html

5. Research on China Diagnostic Reagent Industry, 2015 Data Charts Classification of In Vitro Diagnostic Reagents (by Detection Principle) 2005-2013 Main Policies of China Diagnostic Reagent Industry Industry Chain of Diagnostic Reagent 2009-2014 Market Size of In Vitro Diagnostics in China 2014 Market Structure of China’s In Vitro Diagnostic Reagent 2010-2015 Market Size of China’s Immunodiagnosis Market by Products Domestic Enterprises with Chemiluminescence Immunoassay (CLIA) Products Numbers of DLIA Diagnostic Reagents by Domestic Enterprises 2007-2013 Numbers of Molecular Diagnosis Project in China 2010-2015 Market Size of Biochemical Diagnosis in China Diagnostic Instrument Comparison between Domestic and Foreign Enterprises Competition Pattern of China’s Diagnostic Reagent Industry Read more Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=392985

6. RNR MARKET RESEARCH RNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact : sales@rnrmarketresearch.Com / +18883915441 FOLLOW US Website www.rnrmarketresearch.com